申请人:Ren Pingda
公开号:US20110172228A1
公开(公告)日:2011-07-14
The present invention provides chemical entities or compounds and pharmaceutical compositions thereof that are capable of modulating certain protein kinases such as mTor, tyrosine kinases, and/or lipid kinases such as PI3 kinase. Also provided in the present invention are methods of using these compositions to modulate activities of one or more of these kinases, especially for therapeutic applications.
本发明提供了化学实体或化合物以及其制备的药物组合物,这些药物组合物能够调节某些蛋白激酶,如mTor、酪氨酸激酶和/或脂质激酶,如PI3激酶。本发明还提供了使用这些组合物调节其中一个或多个激酶活性的方法,特别是用于治疗应用。